Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$2.13 - $9.01 $43,792 - $185,245
-20,560 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$6.28 - $15.59 $6,035 - $14,981
961 Added 4.9%
20,560 $164,000
Q4 2021

Feb 02, 2022

BUY
$14.7 - $28.67 $288,105 - $561,903
19,599 New
19,599 $299,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Mirador Capital Partners LP Portfolio

Follow Mirador Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.